Literature DB >> 19118776

Synchronous renal and adrenal masses: an analysis of 80 cases.

Armita Bahrami1, Luan D Truong, Steven S Shen, Bhuvaneswari Krishnan.   

Abstract

Synchronous renal and adrenal masses are uncommon. Although adrenal masses in the context of renal cell carcinoma (RCC) are often suspected as metastasis, other adrenal lesions with different therapeutic and prognostic implications may coexist with RCC. In a retrospective review of 550 radical nephrectomies with ipsilateral adrenalectomy, 80 cases of coexisting renal and adrenal masses were identified. The renal masses included 76 RCCs, 3 oncocytomas, and 1 malignant pheochromocytoma of adrenal gland involving the kidney. Although the gross pathologic impression of adrenal masses in the presence of RCC was metastasis, on histologic examination, 56% of them were found to be benign lesions (mostly adrenal adenoma/hyperplasia), whereas malignant involvement from RCC was seen in 43%. The benign and malignant nature of the adrenal lesions in the context of RCC could not be discriminated based on the size of adrenal mass. Because of the prognostic implication of direct or metastatic involvement of adrenal gland in the setting of RCC and the possibility of finding small metastatic foci, a meticulous gross and microscopic examination of adrenal glands is emphasized. Rare unusual combinations of renal and adrenal lesions such as RCC and adrenal histoplasmosis, RCC and adrenal myelolipoma, renal oncocytoma, and adrenal pheochromocytoma are also described.

Entities:  

Mesh:

Year:  2008        PMID: 19118776     DOI: 10.1016/j.anndiagpath.2008.07.003

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  10 in total

Review 1.  Surgical management of adrenal metastases.

Authors:  Juan J Sancho; Frédéric Triponez; Xavier Montet; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2011-12-16       Impact factor: 3.445

2.  A case report of collecting duct carcinoma of the kidney coexistent with giant adrenal myelolipoma.

Authors:  Bingkun Li; Qiang Ding
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

3.  Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).

Authors:  Sounak Gupta; Jun Zhang; Dragana Milosevic; John R Mills; Stefan K Grebe; Steven C Smith; Lori A Erickson
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

4.  Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma.

Authors:  A N Jeppesen; H K Jensen; F Donskov; N Marcussen; H von der Maase
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

5.  Laparoscopic Nephrectomy with Adrenalectomy for Synchronous Adrenal Myelolipoma and Renal Cell Carcinoma.

Authors:  Kallappan Senthil; Manickam Ramalingam; Karpagam Janardhan; Anandan Murugesan; Mizar Ganapathy Pai
Journal:  Case Rep Urol       Date:  2015-04-29

6.  Synchronous renal cell carcinoma and pheochromocytoma presenting as acute decompensated heart failure.

Authors:  H H Chen; S T Wu; Y C Lin; C S Lin
Journal:  J Postgrad Med       Date:  2019 Jan-Mar       Impact factor: 1.476

7.  Concurrent laparoscopic management of giant adrenal myelolipoma and contralateral renal cell carcinoma.

Authors:  Tarun Jindal; Pravin Pawar; Neeraj Subedi
Journal:  Asian J Urol       Date:  2021-04-30

8.  Tumor-to-tumor metastasis of clear cell renal cell carcinoma to contralateral synchronous pheochromocytoma: A case report.

Authors:  Hsin-Yu Wen; Jing Hou; Hao Zeng; Qiao Zhou; Ni Chen
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

9.  Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors.

Authors:  Giandomenico Roviello; Martina Catalano; Ugo De Giorgi; Marco Maruzzo; Sebastiano Buti; Elisabetta Gambale; Giuseppe Procopio; Carlotta Ottanelli; Enrico Caliman; Luca Isella; Pierangela Sepe; Nicole Brighi; Matteo Santoni; Luca Galli; Raffaele Conca; Laura Doni; Lorenzo Antonuzzo
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

10.  Malignant and Metastatic Pheochromocytoma: Case Report and Review of the Literature.

Authors:  Michael H Johnson; Jaime A Cavallo; R Sherburne Figenshau
Journal:  Urol Case Rep       Date:  2014-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.